Skip to main content

Table 2 Staging of the participants for diabetic kidney disease

From: Ten-year follow-up of sitagliptin treatment in patients with type 2 diabetes mellitus

Staging for diabetic kidney diasese Sitagliptin (n = 17) Control (n = 9)
Time (months) 0 M 120 M 0 M 120 M
Stage I 8 14 4 2
Stage II 7 2 4 6
Stage III 2 1 1 1
Stage IV 0 0 0 0
Stage V 0 0 0 0
  1. Stage I: ACR < 30, Stage II: ACR30 ~ 300, Stage III: ACR > 300
  2. ACR albumin creatinine ratio